Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation

References

• Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in Nordic countries. Int J Cancer 2004; 108:104 - 108
   PubMed Web of Science ®Google Scholar
• Tuohimaa P. Vitamin D, aging and cancer. Nutr Rev 2008; 66:147 - 152
   Web of Science ®Google Scholar
• Tuohimaa P. Vitamin D and aging. J Steroid Biochem Mol Biol 2009; 114:78 - 84
   PubMed Web of Science ®Google Scholar
• Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology in press http://dx.doi.org/10.1016/j.psyneuen.2009.07.003
   PubMedGoogle Scholar
• International Agency for Research on Cancer. Working Group Report 5: Vitamin D and Cancer 2008; Lyon, France IARC
   Google Scholar
• Davis CD. Vitamin D and health: Can too much be harmful?. Am J Lifestyle Med 2009; 3:407 - 408
   Google Scholar
• Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503 - 511
   PubMed Web of Science ®Google Scholar
• Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168:1629 - 1637
   PubMed Web of Science ®Google Scholar
• Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 2006; 66:10213 - 10219
   PubMed Web of Science ®Google Scholar
• Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR, et al. Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Nutr 2007; 97:123 - 128
   Web of Science ®Google Scholar
• Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, Lie B, et al. Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 2007; 16:1889 - 1893
   PubMed Web of Science ®Google Scholar
• Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009; 29:3675 - 3684
   PubMed Web of Science ®Google Scholar
• Lou YR, Molnár F, Peräkylä M, Qiao S, Kalueff AV, St-Arnaud R, et al. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2010; 118:162 - 170
   PubMed Web of Science ®Google Scholar
• Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA. Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 2007; 16:2784 - 2786
   PubMed Web of Science ®Google Scholar
• Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Screening Trial. Cancer Res 2009; 69:1439 - 1447
   PubMed Web of Science ®Google Scholar
• Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85:1586 - 1591
   PubMed Web of Science ®Google Scholar
• Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009; 124:979 - 986
   PubMed Web of Science ®Google Scholar
• Gupta D, Lammersfeld CA, Trukova K, Lis CG. Vitamin D and prostate cancer risk: a review of the epidemiological literature. Prostate Cancer Prostatic Dis 2009; 12:215 - 226
   PubMed Web of Science ®Google Scholar
• Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000; 11:847 - 852
   PubMed Web of Science ®Google Scholar
• Yin L, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol 2009; 33:435 - 445
   PubMed Web of Science ®Google Scholar
• Devesa SS, Grauman DJ, Blot WJ, Pennello GA, Hoover RN, Fraumeni JF Jr. Atlas of Cancer Mortality in the United States, 1950–1994 1999; National Institute of Health NIH Publication No. 99-4564
   Google Scholar
• Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94:1867 - 1875
   PubMed Web of Science ®Google Scholar
• Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26:2687 - 2699
   PubMed Web of Science ®Google Scholar
• Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2000. BMC Cancer 2006; 6:264
   PubMed Web of Science ®Google Scholar
• Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int J Cancer 2007; 120:1123 - 1127
   PubMed Web of Science ®Google Scholar
• Leffell DJ, Brash DE. Sunlight and skin cancer. Sci Am 1996; 275:52 - 59
   PubMed Web of Science ®Google Scholar
• Grant WB, Garland CF, Holick MF. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 2005; 81:1276 - 1286
   PubMed Web of Science ®Google Scholar
• Grant WB. Geographic variation of prostate cancer mortality rates in the United States: Implications for prostate cancer risk related to vitamin D. Int J Cancer 2004; 111:470 - 471
   PubMed Web of Science ®Google Scholar
• Grant WB. Hypothesis-Ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol 2008; 84:356 - 365
   PubMed Web of Science ®Google Scholar
• Colli JL, Grant WB. Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States. Urology 2008; 71:531 - 535
   PubMed Web of Science ®Google Scholar
• Brittingham A, de la Cruz GP. Ancestry 2000. Census 2000 Brief CK2BR-35 2004; Washington DC US Dept. of Commerce CB editor
   Google Scholar
• Grant WB. A multicountry ecological study of risk-modifying factors for prostate cancer: Apolipoprotein E ε4 as a risk factor and cereals as a risk reduction factor. Anticancer Res 2010; 30:189 - 199
   PubMed Web of Science ®Google Scholar
• Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009; 106:16351 - 16356
   PubMed Web of Science ®Google Scholar
• Grant WB. A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol 2004; 45:271 - 279
   PubMed Web of Science ®Google Scholar
• Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk of pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prevention 2006; 15:1688 - 1695
   PubMed Web of Science ®Google Scholar
• Kato I, Tajima K, Kuroishi T, Tominaga S. Latitude and pancreatic cancer. Jpn J Clin Oncol 1985; 15:403 - 413
   PubMed Web of Science ®Google Scholar
• Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys 2004; 87:532 - 538
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Wagatsuma Y, Okada M. Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. Int J Health Geogr 2007; 6:34
   PubMed Web of Science ®Google Scholar
• Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2000. BMC Cancer 2006; 6:264
   PubMed Web of Science ®Google Scholar
• Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int J Cancer 2007; 120:1123 - 1127
   PubMed Web of Science ®Google Scholar
• Neale RE, Youlden DR, Krnjacki L, Kimlin MG, van der Pols JC. Latitude variation in pancreatic cancer mortality in Australia. Pancreas 2009; 38:387 - 390
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: Association or causation?. Proc R Soc Med 1965; 58:295 - 300
   PubMed Web of Science ®Google Scholar
• Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinol 2009; 1:17 - 24
   PubMedGoogle Scholar
• Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113:456 - 463
   PubMed Web of Science ®Google Scholar
• Koshiol J, Wei W, Kreimer AR, Chen W, Gravitt P, Ren JS, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2009; Epub ahead of print
   Google Scholar
• Grant WB. Does solar ultraviolet irradiation affect cancer mortality rates in China?. Asian Pac J Cancer Prev 2007; 8:236 - 242
   PubMed Web of Science ®Google Scholar
• Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168:1340 - 1349
   PubMed Web of Science ®Google Scholar
• Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009; 57:1595 - 1603
   PubMed Web of Science ®Google Scholar
• Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64:203 - 209
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168:1174 - 1180
   PubMed Web of Science ®Google Scholar
• Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliövaara M, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009; 170:1032 - 1039
   PubMed Web of Science ®Google Scholar
• Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 2010; 65:225 - 236
   PubMed Web of Science ®Google Scholar
• Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev 2008; 13:6 - 20
   PubMed Web of Science ®Google Scholar
• Grant WB. A critical review of Vitamin D and cancer: A report of the IARC Working Group on vitamin D. Dermato-Endocrinology 2009; 1:25 - 33
   PubMedGoogle Scholar
• Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik M, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009; 99:104 - 113
   PubMed Web of Science ®Google Scholar
• Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Molec Nutr Food Res In press
   Web of Science ®Google Scholar
• Grant WB. In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance. Dermatoendocrinol 2009; 1:207 - 214
   PubMedGoogle Scholar